Join the club for FREE to access the whole archive and other member benefits.

Glympse Bio

Biotech manufacturing advanced nanoparticle sensors to monitor diseases

Glympse Bio is an MIT spin-out from the laboratory of renowned bioengineer, Dr. Sangeeta Bhatia. Glympse Bio is headquartered in Cambridge, MA.

Glympse Bio develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. 

Visit website: https://glympsebio.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

Mentioned in this Resource

Academia

Private land-grant research university

Academic

Biomedical researcher and John J. and Dorothy Wilson Professor at MIT

Glympse Bio News

New urine test detects cancer cells and their location using nanoparticles

Massachusetts Institute of Technology (MIT) - 15-Jul-2021

Screening cancers non-invasively; shows safety in phase 1 trials

Read more...